Roy A. E. Bakay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roy A. E. Bakay has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Daniel M. Corcos
Department of Kinesiology and Nutrition, University of Illinois at Chicago, 1919 West Taylor, 650 AHSB (M/C 994), Chicago, Illinois, 60612 USA
2 shared publications - Leo Verhagen Metman
Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
2 shared publications David E. Vaillancourt
Illinois Univ., Chicago
1 shared publication- David E. Vaillancourt
Department of Movement Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA
1 shared publication - Janey Prodoehl
Department of Kinesiology and Nutrition, University of Illinois at Chicago, 1919 West Taylor Street, 650 AHSB, M/C 994, Chicago, IL 60612, USA
1 shared publication - John Christine Rothwell
UCL Queen Square Institute of Neurology, London, UK
1 shared publication
Latest Publications
- 1 December 2012
- Published by Elsevier in World Neurosurgery
- Vol. 78 (6) , 576-578
Neural Prosthesis: Concept and Progress
- 1 December 2012
- Published by Elsevier in World Neurosurgery
- Vol. 78 (6) , 576-578
Neural Prosthesis: Concept and Progress
- 30 April 2011
- Published by Elsevier in World Neurosurgery
- Vol. 75 (3-4) , 436-437
Perspectives on “Fusion Image-Based Programming After Subthalamic Nucleus Deep Brain Stimulation”
- 30 April 2011
- Published by Elsevier in World Neurosurgery
- Vol. 75 (3-4) , 436-437
Perspectives on “Fusion Image-Based Programming After Subthalamic Nucleus Deep Brain Stimulation”
- Open Access
- 1 January 2009
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 87 (4) , 266
Deep Brain Stimulation for Schizophrenia
- 1 January 2009
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 87 (4) , 266
Open AccessDeep Brain Stimulation for Schizophrenia
- 18 June 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 15 (2) , 155-165
Effects of STN DBS on Memory Guided Force Control in Parkinson's Disease (June 2007)
This study examined the control of elbow force in nine patients with Parkinson's disease when visual feedback was available and when visual feedback was removed to determine how medication (Meds) and unilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) affect memory guided force control. Patients were examined in each of four treatment conditions: 1) off treatment; 2) Meds; 3) STN DBS; and 4) Meds plus STN DBS. With visual feedback available, there was no difference in force output across treatment conditions. When visual feedback was removed force output drifted under the target in both the off-treatment and the Meds conditions. However, when on STN DBS or Meds plus STN DBS force output drifted above the target. As such, only STN DBS had a significant effect on force output in the vision removed condition. Increased force output when on STN DBS may have occurred due to disruptions in the basal ganglia-thalamo-cortical circuitry. We suggest that modulation of output of the internal segment of the globus pallidus by STN DBS may drive the effect of STN DBS on memory guided force control.
- 18 June 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 15 (2) , 155-165
Effects of STN DBS on Memory Guided Force Control in Parkinson's Disease (June 2007)
This study examined the control of elbow force in nine patients with Parkinson's disease when visual feedback was available and when visual feedback was removed to determine how medication (Meds) and unilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) affect memory guided force control. Patients were examined in each of four treatment conditions: 1) off treatment; 2) Meds; 3) STN DBS; and 4) Meds plus STN DBS. With visual feedback available, there was no difference in force output across treatment conditions. When visual feedback was removed force output drifted under the target in both the off-treatment and the Meds conditions. However, when on STN DBS or Meds plus STN DBS force output drifted above the target. As such, only STN DBS had a significant effect on force output in the vision removed condition. Increased force output when on STN DBS may have occurred due to disruptions in the basal ganglia-thalamo-cortical circuitry. We suggest that modulation of output of the internal segment of the globus pallidus by STN DBS may drive the effect of STN DBS on memory guided force control.
- 18 June 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 15 (2) , 173-181
Effects of STN DBS on Rigidity in Parkinson's Disease
We quantified the effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) and medication on Parkinsonian rigidity using an objective measure of work about the elbow joint during a complete cycle of imposed 1-Hz sinusoidal oscillations. Resting and activated rigidity were analyzed in four experimental conditions: 1) off treatment; 2) on DBS; 3) on medication; and 4) on DBS plus medication. Rigidity at the elbow joint was also assessed using the unified Parkinson's disease rating scale (UPDRS). We tested ten patients who received STN DBS and ten age-matched neurologically healthy control subjects. The activated rigidity condition increased work in both Parkinson's disease (PD) patients and control subjects. In PD patients, STN DBS reduced both resting and activated rigidity as indicated by work and the UPDRS rigidity score. This is the first demonstration that STN stimulation reduces rigidity using an objective measure such as work. In contrast, the presurgery dose of antiParkinsonian medication did not significantly improve the UPDRS rigidity score and reduced work only in the activated rigidity condition. Our results suggest that STN DBS may be more effective in alleviating rigidity in the upper limb of PD patients than medications administered at presurgery dosage level.
- 18 June 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 15 (2) , 173-181
Effects of STN DBS on Rigidity in Parkinson's Disease
We quantified the effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) and medication on Parkinsonian rigidity using an objective measure of work about the elbow joint during a complete cycle of imposed 1-Hz sinusoidal oscillations. Resting and activated rigidity were analyzed in four experimental conditions: 1) off treatment; 2) on DBS; 3) on medication; and 4) on DBS plus medication. Rigidity at the elbow joint was also assessed using the unified Parkinson's disease rating scale (UPDRS). We tested ten patients who received STN DBS and ten age-matched neurologically healthy control subjects. The activated rigidity condition increased work in both Parkinson's disease (PD) patients and control subjects. In PD patients, STN DBS reduced both resting and activated rigidity as indicated by work and the UPDRS rigidity score. This is the first demonstration that STN stimulation reduces rigidity using an objective measure such as work. In contrast, the presurgery dose of antiParkinsonian medication did not significantly improve the UPDRS rigidity score and reduced work only in the activated rigidity condition. Our results suggest that STN DBS may be more effective in alleviating rigidity in the upper limb of PD patients than medications administered at presurgery dosage level.